Difference between revisions of "Team:UCC Ireland"

 
(39 intermediate revisions by 2 users not shown)
Line 1: Line 1:
  
−
<html lang="en">
+
 
 +
<html lang="en" xmlns="http://www.w3.org/1999/html">
 
   <head>
 
   <head>
−
     <link rel="stylesheet" href="https://2016.igem.org/Team:UCC_Ireland/CSS?action=raw&ctype=text/css" />
+
     <meta charset="utf-8">
−
     <link rel="stylesheet" href="https://2016.igem.org/Team:UCC_Ireland/bootstrapcss?action=raw&ctype=text/css" />
+
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
 +
     <meta name="viewport" content="width=device-width, initial-scale=1">
 +
    <!-- The above 3 meta tags *must* come first in the head; any other head content must come *after* these tags -->
 +
 
 +
    <title>UCC iGEM</title>
  
−
     <script type="text/javascript" src="https://2016.igem.org/Template:UCC_Ireland/Javascript?action=raw&ctype=text/javascript"></script>
+
     <!-- Bootstrap core CSS -->
 +
    <link rel="stylesheet" href="https://2016.igem.org/Template:Team:UCC_Ireland/CSS?action=raw&amp;ctype=text/css">
  
 +
    <script src="https://2016.igem.org/Template:Team:UCC_Ireland/JS?action=raw&amp;ctype=text/javascript"></script>
 
      
 
      
−
 
+
  </head>
−
        <!-- Latest compiled and minified JavaScript -->
+
−
        <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script>
+
−
       
+
−
       
+
−
 
+
−
        <!--[if lt IE 9]>
+
−
            <script src="js/vendor/html5-3.6-respond-1.4.2.min.js"></script>
+
−
        <![endif]-->
+
−
    </head>
+
  
 
   <body>
 
   <body>
−
     <div id="wrapper">
+
     <div class="container-full">
−
       <div id="navigation">
+
       <nav class="navbar navbar-inverse navbar-fixed-top">
−
          <nav class="navbar navbar-default navbar-fixed-top" role="navigation">
+
        <div class="container">
−
          <!-- Brand and toggle get grouped for better mobile display -->
+
 
           <div class="navbar-header">
 
           <div class="navbar-header">
−
             <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-ex1-collapse">
+
             <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar">
 
               <span class="sr-only">Toggle navigation</span>
 
               <span class="sr-only">Toggle navigation</span>
 
               <span class="icon-bar"></span>
 
               <span class="icon-bar"></span>
Line 31: Line 28:
 
               <span class="icon-bar"></span>
 
               <span class="icon-bar"></span>
 
             </button>
 
             </button>
 +
              <a class="navbar-brand" href="https://2016.igem.org/Team:UCC_Ireland"><img style="height: 80px;" src="https://static.igem.org/mediawiki/2016/a/a3/LIMITLESSLACTIS-WHITE.png" alt=""></a>
 
           </div>
 
           </div>
−
 
+
           <div id="navbar" class="navbar-collapse collapse">
−
          <!-- Collect the nav links, forms, and other content for toggling -->
+
−
           <div class="collapse navbar-collapse navbar-ex1-collapse">
+
 
             <ul class="nav navbar-nav">
 
             <ul class="nav navbar-nav">
−
                <li class="active"><a href="#">Home</a></li>
+
              <li class="active"><a href="https://2016.igem.org/Team:UCC_Ireland">Home</a></li>
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Project">Project</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Outreach">Outreach</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Team">Team</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Notebook">Notes</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Parts">Parts</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Collaborations">Collaborations</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Interlab_Study">Interlab</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Achievements">Achievements</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Attributions">Attributions</a></li>
+
−
                <li><a href="{{Team:UCC_Ireland/CSS}}">template</a></li>
+
−
 
+
 
               <li class="dropdown">
 
               <li class="dropdown">
 +
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project<span class="caret"></span></a>
 
                 <ul class="dropdown-menu">
 
                 <ul class="dropdown-menu">
−
                   <li class="active"><a href="#">Project</a></li>
+
                   <li><a href="https://2016.igem.org/Team:UCC_Ireland/Limitless_Lactis">Limitless Lactis</a></li>
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Outreach">Outreach</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/iRFP">iRFP In-Vitro Reporter</a></li>
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Team">Team</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Leishmaniasis">Leishmaniasis</a></li>
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Notebook">Notes</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Proof">Proof</a></li>
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Parts">Parts</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Demonstrate">Demonstrate</a></li>
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Collaborations">Collaborations</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Interlab_Study">Interlab</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Achievements">Achievements</a></li>
+
−
                <li><a href="https://2016.igem.org/Team:UCC_Ireland/Attributions">Attributions</a></li>
+
 
                 </ul>
 
                 </ul>
 
               </li>
 
               </li>
 +
              <li class="dropdown">
 +
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Outreach<span class="caret"></span></a>
 +
                <ul class="dropdown-menu">
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/HP/Silver">HP Silver</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/HP/Gold">HP Gold</a></li>
 +
                  <li role="separator" class="divider"></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Engagement">Engagement</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Integrated_Practices">Integrated Practices</a></li>
 +
                </ul>
 +
              </li>
 +
              <li><a href="https://2016.igem.org/Team:UCC_Ireland/Team">Team</a></li>
 +
              <li><a href="https://2016.igem.org/Team:UCC_Ireland/Notebook">Notes</a></li>
 +
              <li><a href="https://2016.igem.org/Team:UCC_Ireland/Parts">Parts</a></li>
 +
              <li class="dropdown">
 +
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Collaborations<span class="caret"></span></a>
 +
                <ul class="dropdown-menu">
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Collaborations">iGEM Teams</a></li>
 +
                  <li role="separator" class="divider"></li>
 +
                  <li class="dropdown-header">Synenergene</li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Application_Scenario">Application Scenario</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Techno_Moral_Newsletter">Techno-Moral Newsletter</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Blog.html">Techno-Moral Blog</a></li>
 +
                </ul>
 +
              </li>
 +
              <li><a href="https://2016.igem.org/Team:UCC_Ireland/Interlab_Study">Interlab</a></li>
 +
              <li><a href="https://2016.igem.org/Team:UCC_Ireland/Achievements">Achievements</a></li>
 +
              <li><a href="https://2016.igem.org/Team:UCC_Ireland/Attributions">Attributions</a></li>
 
             </ul>
 
             </ul>
−
           </div><!-- /.navbar-collapse -->
+
           </div>
−
        </nav>
+
−
      </div>
+
−
  <div id="myCarousel" class="carousel slide" data-ride="carousel">
+
−
      <!-- Indicators -->
+
−
      <ol class="carousel-indicators">
+
−
        <li data-target="#myCarousel" data-slide-to="0" class="active"></li>
+
−
        <li data-target="#myCarousel" data-slide-to="1"></li>
+
−
        <li data-target="#myCarousel" data-slide-to="2"></li>
+
−
      </ol>
+
−
 
+
−
      <!-- Wrapper for slides -->
+
−
      <div class="carousel-inner" role="listbox">
+
−
        <div class="item active">
+
−
          <img src="http://emcscientific.ca/wp-content/uploads/2013/06/bacteria-analysis-bacterium-microscopic.jpg" alt="Chania" width="460" height="345">
+
 
         </div>
 
         </div>
 +
      </nav>
 +
      <div class="container-fluid fix-nav-padding-top">
  
−
         <div class="item">
+
         <div class="row" id="landing">
−
          <img src="http://clackmannanshirebusiness.co.uk/wp-content/uploads/2014/06/Untitled-2-1900x500.jpg" alt="Chania" width="460" height="345">
+
          <div class="col-xs-12 col-md-12">
−
        </div>
+
−
     
+
−
        <div class="item">
+
−
          <img src="http://www.cleaningsupport.com.au/wp-content/uploads/2014/11/1900x500-House.jpg" alt="Flower" width="460" height="345">
+
−
        </div>
+
−
      </div>
+
  
−
      <!-- Left and right controls -->
+
            <img style="width: 400px; display:block; margin:auto;" src="https://static.igem.org/mediawiki/2016/6/6b/T--UCC_Ireland--LIMITLESSLACTIS-BLACK.png" alt="">
−
      <a class="left carousel-control" href="#myCarousel" role="button" data-slide="prev">
+
           
−
        <span class="" aria-hidden="true"></span>
+
          </div>
−
        <span class="sr-only">Previous</span>
+
        </div><!-- /landing -->
−
      </a>
+
       
−
      <a class="right carousel-control" href="#myCarousel" role="button" data-slide="next">
+
 
−
         <span class="" aria-hidden="true"></span>
+
        <div class="row text-center" id="abstract">
−
        <span class="sr-only">Next</span>
+
          <div class="col-xs-12 col-md-8 col-md-offset-2">
−
      </a>
+
            <h2 class="text-center"><span>Limitless Lactis:</span> Intelligent <em>Lactococcus lactis</em> strains as a protein delivery platform for disease treatment.</h2>
−
    </div>
+
    <hr>
 +
              <p class="lead text-left">
 +
              <em>Lactococcus lactis</em>, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic <em>L. lactis</em>-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, <em>Lutzomyia longipalpis</em>. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.
 +
            </p>
 +
              <hr>
 +
              <div align="center" class="embed-responsive embed-responsive-16by9">
 +
                <video controls class="embed-responsive-item">
 +
                  <source src="https://static.igem.org/mediawiki/2016/e/e3/T--UCC_Ireland--I-Like-It-Lactis-UCC-iGEM-2016-SONG.mp4" type="video/mp4">
 +
                </video>
 +
              </div>
 +
          </div>
 +
         </div><!-- /abstract -->
 +
        <br>
 +
        <br>
 +
        <br>
 +
        <br>
 +
        <hr>
 +
 
 +
        <div class="row" id="sponsors">
 +
          <div class="col-xs-12 col-md-11 col-md-11 text-center text-uppercase">
 +
            <div class="row">
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="http://apc.ucc.ie/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/f/f3/T--UCC_Ireland--apc.png" alt=""></a>
 
   </div>
 
   </div>
−
<hr>
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
      <section class="container">
+
    <a href="http://www.ccrc.ie/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/a/a6/T--UCC_Ireland--ccrc.png" alt=""></a>
−
        <div class="well">
+
  </div>
−
            <h2>Abstract</h2>
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
            <p>Lactococcus lactis, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.</p>
+
    <a href="https://www.ucc.ie/en/med-health/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/2/20/T--UCC_Ireland--COMH.jpg" alt=""></a>
−
         </div>
+
  </div>
−
       </section>
+
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="http://www.fyffes.us/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/f/f8/T--UCC_Ireland--Fyffes_SVG_logo.svg.png" alt=""></a>
 +
  </div>
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="http://www.genscript.com/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/5/5b/T--UCC_Ireland--genscripteditkevin.png" alt=""></a>
 +
  </div>
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="http://www.lilly.ie/en/index.aspx" target="_blank"><img src="https://static.igem.org/mediawiki/2016/7/73/T--UCC_Ireland--hutchinsonlilly-2vd3ujlywuaxuzb5zmonpc.jpg" alt=""></a>
 +
  </div>
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="http://eu.idtdna.com/site" target="_blank"><img src="https://static.igem.org/mediawiki/2016/b/b0/T--UCC_Ireland--IDT_logo_trans.png" alt=""></a>
 +
  </div>
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="http://www.janssen.com/ireland/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/6/65/T--UCC_Ireland--Janssen.jpg" alt=""></a>
 +
  </div>
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="https://www.synenergene.eu/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/e/ef/T--UCC_Ireland--logo%281%29.png" alt=""></a>
 +
  </div>
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="https://www.ucc.ie/en/biochemistry/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/0/03/T--UCC_Ireland--schoolofbiochemlogoeditkevin.png" alt=""></a>
 +
  </div>
 +
  <div class="col-xs-4 col-md-1 col-lg-1">
 +
    <a href="http://www.ucc.ie/en/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/4/47/T--UCC_Ireland--ucc.png" alt=""></a>
 +
  </div>
 +
</div>
 +
            <br>
 +
            <br>
 +
            <br>
 +
            <br>
 +
          </div>
 +
         </div><!-- /sponsors -->
 +
            <br>
 +
            <br>
 +
            <br>
 +
            <br>
 +
          </div>
 +
        </div><!-- /sponsors -->
 +
 
 +
        <hr>
 +
 
 +
       </div><!-- /home -->
 +
    </div> <!-- /container full -->
  
−
    <!-- Bootstrap core JavaScript
 
−
    ================================================== -->
 
−
    <!-- Placed at the end of the document so the pages load faster -->
 
−
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.12.4/jquery.min.js"></script>
 
−
    <script>window.jQuery || document.write('<script src="js/vendor/jquery.min.js"><\/script>')</script>
 
−
    <script src="https://2016.igem.org/Team:UCC_Ireland/bootstrap?action=raw&ctype=text/javascript"></script>
 
−
    <!-- IE10 viewport hack for Surface/desktop Windows 8 bug -->
 
−
    <script src="js/ie10-viewport-bug-workaround.js"></script>
 
 
   </body>
 
   </body>
 
</html>
 
</html>

Latest revision as of 00:07, 20 October 2016


UCC iGEM

Limitless Lactis: Intelligent Lactococcus lactis strains as a protein delivery platform for disease treatment.

Lactococcus lactis, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.